Biopharma contributes to key global health discussions at WHA69
Find out here our take on the 69th World Health Assembly (WHA69) with some key relevant links included!
Read More
Pharmacovigilance of biotherapeutic medicines
A new study released in June 2016 identifying global case studies illustrating successes and challenges. A must read!
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2018-01-24 16:23:21
The African Global Health Leaders Fellowship launched to support the future of health in Africa
The African Global Health Leaders Fellowship launched to support the future of health in Africa Geneva, 24 January 2018│ The ...
Read More2018-01-18 06:30:28
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come
The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical ...
Read More2017-12-15 08:00:20
Greg Perry Joins International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as new Assistant Director General
Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical industry association, today announced the ...
Read More2017-12-14 00:40:34
Pharma supports “Reaching a Billion – ending Neglected Tropical Diseases Gateway to UHC” report and call to action
Pharma supports “Reaching a Billion – ending Neglected Tropical Diseases Gateway to UHC” report and ...
Read More2017-12-13 08:42:44
10th annual G-FINDER report: Pharmaceutical industry R&D investment funding for neglected diseases continues to be a good news story
10th annual G-FINDER report: Pharmaceutical industry R&D investment funding for neglected diseases continues to be ...
Read More2017-11-28 11:10:07
Press Release: 3rd Biennial Scientific Conference on Medical Products Regulation in Africa
*3rd Biennial Scientific Conference on Medical Products Regulation in Africa* PRESS RELEASE, 27 November 2017, ...
Read More2017-11-01 13:52:03
IFPMA names new Communications Director
Appointment Release International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) names new Communications Director ...
Read More
Latest Statement
2018-03-23 00:00:47
IFPMA Statement: Biopharmaceutical industry marks World TB Day
Geneva, 23 March 2018 – IFPMA, the world body representing biopharmaceutical companies, confirms its commitment to the World Health Organization ...
Read More2018-01-25 10:22:29
IFPMA Statement @EB 142: Global strategy and plan of action on public health, innovation and intellectual property
Appointment Release International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ...
Read More2018-01-24 09:45:31
IFPMA Statement @EB 142 :Addressing the global shortage of, and access to, medicines and vaccines
Appointment Release International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ...
Read More2017-11-22 15:24:27
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Statement EB Special session on the draft Thirteenth General Programme of Work
Appointment Release International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ...
Read More2017-10-13 08:31:02
Contribution to the public web-based consultation on the Draft concept note towards WHO’s 13th General Programme of Work 2019–2023
Appointment Release International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ...
Read More2017-10-12 08:28:56
IFPMA-EFPIA Statement - Global call for action on drug-resistant infections, 12-13 October 2017, Berlin (Conference organized by Wellcome Trust)
Appointment Release International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ...
Read More2017-10-12 08:25:01
AMR Industry Alliance Statement - Global call for action on drug-resistant infections, 12-13 October 2017, Berlin (Conference organized by Wellcome Trust)
Appointment Release International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
What a difference 70 years can make in global health
This blog was first published on Diplomatic Courier on 11 April 2018. 1948 saw the birth of the UK’s National Health Service providing healthcare free for all at the point of delivery - and 55 countries meet for the inaugural World Health Assembly. Seven decades later, Ebola and Zika outbreaks, old diseases reappearing in conflict zones, polio that is still resisting eradication, chronic “life-style”...
Read More
Accelerating the development and delivery of new innovations for a TB-free world
Before the World Economic Forum, Davos’ first claim to fame was as a haven for wealthy tuberculosis sufferers in the 1800s and 1900s: the rarefied air of the Magic Mountain, as Thomas Mann dubbed it, offered a “certain” cure. The Davos visitors of those days, like Mann’s Hans Castorp, were a small minority of TB sufferers. Today, as then, TB is a disease linked to...
Read More
How smart boxes are helping vaccine makers deliver more
Here we speak with Michaël Attlan, Head of the New Technologies (NT) Platform at Sanofi Pasteur, about how technology is transforming vaccine delivery. Prior to heading the NT Platform, Michaël led Sanofi Pasteur’s Traveler & Endemic Vaccine Franchise. His work in yellow fever, cholera, rabies, and Japanese encephalitis reflects his and Sanofi Pasteur’s commitment to public health around the world. Vaccine demand has risen steadily for...
Read MoreLatest Tweets
@IFPMA @IFPMA 
@IFPMA @IFPMA @IFPMA 